We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
+6.68%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$18.7B
AUM Growth
+$1.89B
(+11%)
Cap. Flow
+$1.31B
Cap. Flow
% of AUM
7.02%
Top 10 Holdings %
Top 10 Hldgs %
10.01%
Holding
3,237
New
779
Increased
845
Reduced
690
Closed
834
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$109M |
| 2 |
Norwegian Cruise Line
NCLH
|
+$105M |
| 3 |
Goldman Sachs
GS
|
+$104M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$101M |
| 5 |
Steel Dynamics
STLD
|
+$99.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$176M |
| 2 |
Coca-Cola
KO
|
+$151M |
| 3 |
Broadcom
AVGO
|
+$146M |
| 4 |
Microsoft
MSFT
|
+$140M |
| 5 |
ExxonMobil
XOM
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.93% |
| 2 | Industrials | 11.65% |
| 3 | Consumer Discretionary | 11.56% |
| 4 | Healthcare | 11.56% |
| 5 | Financials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
CALL
Mastercard
MA
$477B
| $9.56M | 0.05% |
27,500
| – | – |
|
502
US Bancorp
USB
$99.6B
| $9.54M | 0.05% |
218,700
-1,240,442
| -85% | -$53.1M |
|
503
CALL
Cisco
CSCO
$450B
| $9.53M | 0.05% |
200,000
| – | – |
|
504
NetEase
NTES
$76.5B
| $9.52M | 0.05% |
131,053
-95,507
| -42% | -$6.5M |
|
505
Insulet
PODD
$11.3B
| $9.5M | 0.05% |
+32,259
| New | +$8.9M |
|
506
Sherwin-Williams
SHW
$78.3B
| $9.45M | 0.05% |
39,825
-57,905
| -59% | -$13.4M |
|
507
Immunocore
IMCR
$1.78B
| $9.44M | 0.05% |
+165,465
| New | +$9.31M |
|
508
Revvity
RVTY
$12.3B
| $9.41M | 0.05% |
+67,104
| New | +$9.03M |
|
509
Tetra Tech
TTEK
$8.23B
| $9.39M | 0.05% |
323,270
+257,350
| +390% | +$7.44M |
|
|
LHCG
510
DELISTED
LHC Group LLC
LHCG
| $9.33M | 0.05% |
57,722
+31,380
| +119% | +$5.18M |
|
|
VVNT
511
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $9.28M | 0.05% |
+780,084
| New | +$7.02M |
|
512
Royal Bank of Canada
RY
$291B
| $9.23M | 0.05% |
+98,173
| New | +$9.27M |
|
513
International Paper
IP
$22.3B
| $9.21M | 0.05% |
265,940
+244,216
| +1,124% | +$8.44M |
|
|
KNBE
514
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $9.2M | 0.05% |
+371,306
| New | +$9.04M |
|
515
Carvana
CVNA
$43.3B
| $9.09M | 0.05% |
+9,591,690
| New | +$20.3M |
|
|
LBAI
516
DELISTED
Lakeland Bancorp Inc
LBAI
| $9.06M | 0.05% |
514,270
+279,129
| +119% | +$4.98M |
|
517
JetBlue
JBLU
$1.96B
| $8.98M | 0.05% |
1,386,082
+427,373
| +45% | +$3.12M |
|
518
Waste Management
WM
$95.9B
| $8.97M | 0.05% |
57,160
-87,922
| -61% | -$14.1M |
|
519
State Street SPDR S&P Metals & Mining ETF
XME
$4.05B
| $8.85M | 0.05% |
177,741
+96,787
| +120% | +$4.8M |
|
520
Gold Fields
GFI
$29.2B
| $8.83M | 0.05% |
853,257
+723,431
| +557% | +$7.01M |
|
521
Shopify
SHOP
$148B
| $8.7M | 0.05% |
+250,617
| New | +$8.56M |
|
522
Toyota
TM
$210B
| $8.58M | 0.05% |
62,851
+46,778
| +291% | +$6.52M |
|
523
Sun Life Financial
SLF
$45.6B
| $8.53M | 0.05% |
183,741
+60,161
| +49% | +$2.66M |
|
524
Jack Henry & Associates
JKHY
$10.7B
| $8.49M | 0.05% |
48,338
-87,026
| -64% | -$16.1M |
|
525
Pilgrim's Pride
PPC
$6.82B
| $8.47M | 0.05% |
357,021
-58,009
| -14% | -$1.38M |
|
Similar funds
Qube Research & Technologies (QRT)'s Q4 2022 Portfolio in Review
As of Q4 2022, Qube Research & Technologies (QRT) held 3,237 positions worth $18.7B, up 11% from $16.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $1.31B of net new capital in Q4 2022, opening 779 new positions and adding to 845 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,451,017 shares worth $104M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $140M trimmed.
- Qube Research & Technologies (QRT)'s largest Q4 2022 buy was Bristol-Myers Squibb: 1,451,017 shares worth $104M.
- Qube Research & Technologies (QRT) added most to Goldman Sachs in Q4 2022, an estimated $104M increase.
- Qube Research & Technologies (QRT)'s biggest Q4 2022 reduction was Microsoft, cutting an estimated $140M.
- Qube Research & Technologies (QRT) fully exited Chevron in Q4 2022, selling an estimated $176M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $18.7B portfolio in Q4 2022.
- Qube Research & Technologies (QRT) opened 779 new positions and closed 834 in Q4 2022.
- Qube Research & Technologies (QRT)'s portfolio value rose 11% quarter-over-quarter to $18.7B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.